HomeAIMI • OTCMKTS
add
AIM ImmunoTech Inc
Nakaraang pagsara
$0.085
Sakop ng araw
$0.079 - $0.090
Sakop ng taon
$0.025 - $0.12
Market cap
6.13M USD
Average na Volume
300.82K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 16.00K | -60.00% |
Gastos sa pagpapatakbo | 3.62M | -37.13% |
Net na kita | -3.70M | 36.31% |
Net profit margin | -23.16K | -59.23% |
Kita sa bawat share | -0.05 | 58.33% |
EBITDA | -3.56M | 37.26% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.25M | -79.46% |
Kabuuang asset | 6.25M | -61.41% |
Kabuuang sagutin | 10.10M | -11.07% |
Kabuuang equity | -3.86M | — |
Natitirang share | 76.42M | — |
Presyo para makapag-book | -1.70 | — |
Return on assets | -121.80% | — |
Return on capital | -6,371.48% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -3.70M | 36.31% |
Cash mula sa mga operasyon | -2.36M | 50.97% |
Cash mula sa pag-invest | 898.00K | 668.35% |
Cash mula sa financing | 660.00K | -76.67% |
Net change in cash | -803.00K | 62.55% |
Malayang cash flow | -1.82M | 34.19% |
Tungkol
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Itinatag
1966
Headquarters
Website
Mga Empleyado
22
